Doug King

2.0k total citations
15 papers, 1.5k citations indexed

About

Doug King is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Virology. According to data from OpenAlex, Doug King has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Biological Psychiatry and 3 papers in Virology. Recurrent topics in Doug King's work include Tryptophan and brain disorders (4 papers), HIV Research and Treatment (3 papers) and Stress Responses and Cortisol (2 papers). Doug King is often cited by papers focused on Tryptophan and brain disorders (4 papers), HIV Research and Treatment (3 papers) and Stress Responses and Cortisol (2 papers). Doug King collaborates with scholars based in United States, United Kingdom and Denmark. Doug King's co-authors include Hagop S. Akiskal, Ted L. Rosenthal, H. Bobby Gaspar, Hélio Lemmi, Boghos I. Yerevanian, Christine Kinnon, Kimberly Gilmour, Adrian J. Thrasher, Joanna Sinclair and Paul Veys and has published in prestigious journals such as The Lancet, Blood and American Journal of Psychiatry.

In The Last Decade

Doug King

15 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doug King United States	11	579	495	409	281	254	15	1.5k
W. Louise Warren United States	17	495 0.9×	135 0.3×	400 1.0×	24 0.1×	193 0.8×	17	1.4k
Giovanni Biasi Italy	21	133 0.2×	185 0.4×	368 0.9×	126 0.4×	44 0.2×	85	1.5k
Matti Iivanainen Finland	21	178 0.3×	163 0.3×	184 0.4×	83 0.3×	137 0.5×	50	1.4k
Torrey Seland Canada	15	147 0.3×	185 0.4×	117 0.3×	142 0.5×	83 0.3×	31	1.5k
Andrew R. Gilbert United States	18	69 0.1×	128 0.3×	208 0.5×	87 0.3×	465 1.8×	33	1.3k
Charles P. Miles United States	15	165 0.3×	199 0.4×	226 0.6×	100 0.4×	277 1.1×	33	885
Shekeeb S. Mohammad Australia	22	274 0.5×	257 0.5×	256 0.6×	114 0.4×	145 0.6×	72	2.1k
Cindy Schneider Italy	19	609 1.1×	496 1.0×	220 0.5×	68 0.2×	103 0.4×	51	1.8k
Deb K. Pal United Kingdom	28	920 1.6×	504 1.0×	1.3k 3.2×	73 0.3×	110 0.4×	101	2.7k
Paolo Mariotti Italy	24	135 0.2×	265 0.5×	260 0.6×	41 0.1×	35 0.1×	68	1.4k

Countries citing papers authored by Doug King

Since Specialization

Citations

This map shows the geographic impact of Doug King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug King more than expected).

Fields of papers citing papers by Doug King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug King. The network helps show where Doug King may publish in the future.

Co-authorship network of co-authors of Doug King

This figure shows the co-authorship network connecting the top 25 collaborators of Doug King. A scholar is included among the top collaborators of Doug King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug King. Doug King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gaspar, H. Bobby, Kimberly Gilmour, Doug King, et al.. (2006). Successful Reconstitution of Immunity in ADA-SCID by Stem Cell Gene Therapy Following Cessation of PEG-ADA and Use of Mild Preconditioning. Molecular Therapy. 14(4). 505–513. 144 indexed citations

Gaspar, H. Bobby, Kathryn L. Parsley, Steven J. Howe, et al.. (2004). Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. The Lancet. 364(9452). 2181–2187. 476 indexed citations

Rao, Kanchan, Persis Amrolia, Alison Jones, et al.. (2004). Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood. 105(2). 879–885. 155 indexed citations

Rossi, Anita De, et al.. (2002). Increased Thymic Output after Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus Type 1–Infected Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. The Journal of Infectious Diseases. 186(3). 312–320. 61 indexed citations

King, Doug, et al.. (2001). T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART). Clinical & Experimental Immunology. 125(3). 447–454. 14 indexed citations

King, Doug & Eva‐Lotta Larsson‐Sciard. (2001). Clonal evolution of CD8+ T-cell expansions in HIV-infected patients on long-term HAART. Clinical & Experimental Immunology. 126(2). 280–286. 8 indexed citations

King, Doug, et al.. (1987). Rapid Normalization of the Dexamethasone Suppression Test with Mianserin. International Clinical Psychopharmacology. 2(2). 111–116. 3 indexed citations

Akiskal, Hagop S., Boghos I. Yerevanian, Glenn C. Davis, Doug King, & Hélio Lemmi. (1985). The nosologic status of borderline personality: clinical and polysomnographic study. American Journal of Psychiatry. 142(2). 192–198. 118 indexed citations

Greden, John F., Robert Gardner, Doug King, et al.. (1983). Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Journal of Clinical Psychopharmacology. 3(5). 327–327. 3 indexed citations

10.

Akiskal, Hagop S., et al.. (1983). Bipolar outcome in the course of depressive illness. Journal of Affective Disorders. 5(2). 115–128. 312 indexed citations

11.

Akiskal, Hagop S., et al.. (1982). The utility of the REM latency test in psychiatric diagnosis: A study of 81 depressed outpatients. Psychiatry Research. 7(1). 101–110. 69 indexed citations

12.

King, Doug, et al.. (1982). The dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect. Psychiatry Research. 7(1). 93–99. 12 indexed citations

13.

King, Doug, et al.. (1981). REM density in the differential diagnosis of psychiatric from medical-neurologic disorders: A replication. Psychiatry Research. 5(3). 267–276. 27 indexed citations

14.

Akiskal, Hagop S., et al.. (1981). Chronic depressions. Journal of Affective Disorders. 3(3). 297–315. 113 indexed citations

15.

King, Doug. (1980). Sleep Deprivation Therapy in Depression Syndromes. Psychosomatics. 21(5). 404–407. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact